Risk of thromboembolic events in patients with atrial flutter.

PubWeight™: 2.19‹?› | Rank: Top 2%

🔗 View Article (PMID 9732883)

Published in Am J Cardiol on September 01, 1998

Authors

K Seidl1, B Hauer, N G Schwick, D Zellner, R Zahn, J Senges

Author Affiliations

1: Herzzentrum Ludwigshafen, Cardiology, Germany.

Articles by these authors

Industrial biocatalysis today and tomorrow. Nature (2001) 4.99

NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A (2000) 2.56

Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis (2007) 2.21

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J (1999) 2.13

ClpS is an essential component of the N-end rule pathway in Escherichia coli. Nature (2006) 2.09

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics (2001) 1.91

Suppression of defective RAS1 and RAS2 functions in yeast by an adenylate cyclase activated by a single amino acid change. EMBO J (1986) 1.90

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol (2001) 1.82

A structural model for GroEL-polypeptide recognition. Proc Natl Acad Sci U S A (1997) 1.82

Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J (2001) 1.69

[New recommendations for contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Pneumologie (2011) 1.68

The WASp homologue Las17p functions with the WIP homologue End5p/verprolin and is essential for endocytosis in yeast. Curr Biol (1998) 1.68

Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill (2014) 1.66

Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J (1999) 1.66

The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart (2010) 1.64

Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients. Cathet Cardiovasc Diagn (1997) 1.62

[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]. Z Rheumatol (2009) 1.58

Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis (2006) 1.54

Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol (2000) 1.49

[Guidelines for drug treatment of tuberculosis in adults and childhood]. Pneumologie (2001) 1.47

Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Invasive Cardiol (2001) 1.46

The patient with acute myocardial infarction who does not receive reperfusion treatment. Heart (2001) 1.43

Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res (1999) 1.43

The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J (1998) 1.42

Incidence of analgesic nephropathy in Berlin since 1983. Nephrol Dial Transplant (1999) 1.42

Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease. Blood Coagul Fibrinolysis (2002) 1.41

Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Heart (1999) 1.39

[Long-term therapy after an acute myocardial infarct]. Dtsch Med Wochenschr (1992) 1.39

Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv (1999) 1.39

[Diagnosis of pulmonary embolism]. Dtsch Med Wochenschr (1996) 1.38

Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation (2001) 1.38

"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol (2004) 1.28

NMR structures of three single-residue variants of the human prion protein. Proc Natl Acad Sci U S A (2000) 1.28

Control of Tn7 transposition. Mol Gen Genet (1984) 1.26

Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol (1995) 1.24

Altered receptor subtypes in the forebrain of GABA(A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. Neuroscience (2002) 1.23

Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14

Targeted disruption of the GABA(A) receptor delta subunit gene leads to an up-regulation of gamma 2 subunit-containing receptors in cerebellar granule cells. J Biol Chem (2001) 1.13

[Recommendations for therapy, chemoprevention and chemoprophylaxis of tuberculosis in adults and children. German Central Committee against Tuberculosis (DZK), German Respiratory Society (DGP)]. Pneumologie (2012) 1.12

Physical structure, genetic content and expression of the alkBAC operon. Mol Gen Genet (1984) 1.10

Mammalian skeletal muscle: reduced chloride conductance in drug-induced myotonia and induction of myotonia by low-chloride solution. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.10

Refolding chromatography with immobilized mini-chaperones. Proc Natl Acad Sci U S A (1997) 1.09

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol (2005) 1.09

[Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Gesundheitswesen (2007) 1.08

Virtual DNA analysis--a new tool for combination and standardised evaluation of SSO, SSP and sequencing-based typing results. Tissue Antigens (1998) 1.07

The Tn5 bleomycin resistance gene confers improved survival and growth advantage on Escherichia coli. Mol Gen Genet (1994) 1.06

Presynaptic depolarization of cutaneous mechanoreceptor afferents after mechanical skin stimulation. Exp Brain Res (1967) 1.05

An improved colony-PCR method for filamentous fungi for amplification of PCR-fragments of several kilobases. J Biotechnol (1997) 1.04

Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04

Ectopic expression of the GABA(A) receptor alpha6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology (2002) 1.04

The role of Pavlovian conditioning in the acquisition of food likes and dislikes. Ann N Y Acad Sci (1985) 1.04

Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol (2000) 1.03

[Latent tuberculosis infection in healthcare workers--evaluation of an Interferon-gamma release assay]. Pneumologie (2007) 1.02

Methodological issues in quantifying the magnitude of the tuberculosis problem in a prison population. Int J Tuberc Lung Dis (2011) 1.02

[Recommendations for background studies in tuberculosis]. Pneumologie (2007) 1.01

Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol (2001) 1.00

Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev (2003) 1.00

Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J (2001) 1.00

Nucleotide sequence of the 18S rDNA from the microalga Nanochlorum eucaryotum. Nucleic Acids Res (1988) 1.00

Tuberculosis in the elderly in Germany. Eur Respir J (2011) 1.00

Xylene monooxygenase catalyzes the multistep oxygenation of toluene and pseudocumene to corresponding alcohols, aldehydes, and acids in Escherichia coli JM101. J Biol Chem (2000) 0.99

The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol (2007) 0.98

Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol (1998) 0.98

[Lead-related complications in 340 patients with an implantable cardiverter/defibrillator]. Z Kardiol (1999) 0.98

Yeast mutants temperature-sensitive for growth after random mutagenesis of the chromosomal RAS2 gene and deletion of the RAS1 gene. EMBO J (1988) 0.97

Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABA(A) receptor beta2-alpha6-alpha1-gamma2 subunit gene cluster. Mol Cell Neurosci (2000) 0.96

[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]. Pneumologie (2009) 0.95

Regeneration of the GTP-bound from the GDP-bound form of human and yeast ras proteins by nucleotide exchange. Stimulatory effect of organic and inorganic polyphosphates. Eur J Biochem (1986) 0.95

The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95

NMR analysis of the binding of a rhodanese peptide to a minichaperone in solution. J Mol Biol (1999) 0.94

Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Z Kardiol (2005) 0.94

Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarction. Z Kardiol (2003) 0.92

Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol (1999) 0.92

The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J (1997) 0.92

Effect of hypoxia on the sinoatrial node, atrium, and atrioventricular node in the rabbit heart. Circ Res (1979) 0.92

Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab (2000) 0.91

In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Heart (2005) 0.91

Standardized structure and modular design of a pharmacokinetic database. Comput Methods Programs Biomed (1998) 0.91

Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia. Am J Cardiol (1984) 0.91

Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]). Am J Cardiol (2001) 0.90

[Berlin Declaration on Tuberculosis: High Level Follow-Up of High Priority Countries for TB Control in the WHO-EURO Region 'Double Trouble or Double Success? Bringing Together Diseases and Programs' - a symposium report]. Pneumologie (2010) 0.90

Transmission electron microscopy of GroEL, GroES, and the symmetrical GroEL/ES complex. J Struct Biol (1995) 0.90

Altered cardiac automaticity and conduction in experimental diabetes mellitus. J Mol Cell Cardiol (1980) 0.90

Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study. Acta Diabetol (2003) 0.89

Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy. Biopolymers (1999) 0.89

Role of glycine-82 as a pivot point during the transition from the inactive to the active form of the yeast Ras2 protein. FEBS Lett (1991) 0.89

Thermodynamic stability and folding of GroEL minichaperones. J Mol Biol (1998) 0.89

Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study. Int J Cardiol (2013) 0.89

Transient left ventricular dysfunction with apical ballooning (tako-tsubo cardiomyopathy) in Germany. Clin Res Cardiol (2006) 0.89

[Cardiogenic shock after adrenalectomy for pheochromocytoma]. Internist (Berl) (2007) 0.89

[Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany]. Pneumologie (2004) 0.89

Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia. Circulation (1984) 0.88